title: Mycobacterium tuberculosis: an infection we should suspect in bone marrow transplantation.
authors: E
authors: E
authors: Zanet
authors: R
authors: R
authors: Manuele
authors: M
authors: M
authors: Michieli
authors: M
authors: M
authors: Rupolo
authors: M
authors: M
authors: Berretta
authors: F
authors: F
authors: Florio
authors: G
authors: G
authors: Basaglia
authors: A
authors: A
authors: Camporese
authors: U
authors: U
authors: Tirelli
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000276:immunology*; D002945:Cisplatin / Q000009:adverse effects / Q000627:therapeutic use; D003561:Cytarabine / Q000009:adverse effects / Q000627:therapeutic use; D003907:Dexamethasone / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000009:adverse effects; D006801:Humans; D016867:Immunocompromised Host; D055985:Latent Tuberculosis / Q000188:drug therapy / Q000276:immunology* / Q000382:microbiology / Q000652:urine; D008207:Lymphatic Metastasis; D008297:Male; D009169:Mycobacterium tuberculosis / Q000276:immunology* / Q000302:isolation & purification; D009378:Neoplasms, Multiple Primary / Q000188:drug therapy / Q000628:therapy; D012074:Remission Induction; D016879:Salvage Therapy; D016896:Treatment Outcome
chemical_list: D000995:Antitubercular Agents; D003561:Cytarabine; D003907:Dexamethasone; D002945:Cisplatin